Detalhe da pesquisa
1.
Cross-activating c-Met/ß1 integrin complex drives metastasis and invasive resistance in cancer.
Proc Natl Acad Sci U S A
; 114(41): E8685-E8694, 2017 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973887
2.
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment.
Cells
; 12(4)2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831214
3.
Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.
Mol Cancer Ther
; 22(9): 1100-1111, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440705
4.
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience.
J Pers Med
; 12(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579573
5.
PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.
J Biol Chem
; 284(38): 26070-84, 2009 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19628872
6.
Tissues Harvested Using an Automated Surgical Approach Confirm Molecular Heterogeneity of Glioblastoma and Enhance Specimen's Translational Research Value.
Front Oncol
; 9: 1119, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750239
7.
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.
JCI Insight
; 2(2): e88815, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138554
8.
Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.
Oncotarget
; 7(11): 12718-30, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863637
9.
Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells.
Cancer Res
; 75(24): 5355-66, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26573800